dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pantaleo, Maria Abbondanza |
dc.contributor.author | Heinrich, Michael C. |
dc.contributor.author | Italiano, Antoine |
dc.contributor.author | Valverde Morales, Claudia Maria |
dc.contributor.author | Schöfski, Patrick |
dc.contributor.author | Grignani, Giovanni |
dc.date.accessioned | 2022-09-12T10:10:45Z |
dc.date.available | 2022-09-12T10:10:45Z |
dc.date.issued | 2022-05-06 |
dc.identifier.citation | Pantaleo MA, Heinrich MC, Italiano A, Valverde C, Schöffski P, Grignani G, et al. A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer. 2022 May 6;22:511. |
dc.identifier.issn | 1471-2407 |
dc.identifier.uri | https://hdl.handle.net/11351/8159 |
dc.description | Alpelisib; Tumor estromal gastrointestinal; Imatinib |
dc.description.sponsorship | The study was funded by the Novartis Pharma AG, Basel, Switzerland. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | BMC Cancer;22 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Aparell digestiu - Càncer - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Gastrointestinal Stromal Tumors |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.title | A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12885-022-09610-4 |
dc.subject.decs | tumores del estroma gastrointestinal |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1186/s12885-022-09610-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pantaleo MA] Division in Medical Oncology, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. [Heinrich MC] Portland VA Health Care System and Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon, USA. [Italiano A] Institut Bergonie, Bordeaux, France. [Valverde C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Schöffski P] Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. [Grignani G] Division of Medical Oncology, Candiolo Cancer Institute, TO, Italy |
dc.identifier.pmid | 35524239 |
dc.identifier.wos | 000791786100010 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |